2-(3-Ethyl-[1,2,4]triazol-1-yl)-1-((S)-2-(2-hydroxy-ethyl)-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl)-ethanone

ID: ALA5281798

Chembl Id: CHEMBL5281798

Max Phase: Preclinical

Molecular Formula: C21H22F6N8O2S

Molecular Weight: 564.52

Associated Items:

Names and Identifiers

Canonical SMILES:  CCc1ncn(CC(=O)N2CCN(c3sc(C(F)(F)F)nc3-c3cnc(C(F)(F)F)nc3)C[C@@H]2CCO)n1

Standard InChI:  InChI=1S/C21H22F6N8O2S/c1-2-14-30-11-34(32-14)10-15(37)35-5-4-33(9-13(35)3-6-36)17-16(31-19(38-17)21(25,26)27)12-7-28-18(29-8-12)20(22,23)24/h7-8,11,13,36H,2-6,9-10H2,1H3/t13-/m0/s1

Standard InChI Key:  WYHMARFYRUASMT-ZDUSSCGKSA-N

Alternative Forms

  1. Parent:

    ALA5281798

    ---

Associated Targets(Human)

CXCR3 Tchem C-X-C chemokine receptor type 3 (2736 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 564.52Molecular Weight (Monoisotopic): 564.1491AlogP: 2.89#Rotatable Bonds: 7
Polar Surface Area: 113.16Molecular Species: NEUTRALHBA: 10HBD: 1
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 2.06CX LogP: 2.83CX LogD: 2.83
Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.44Np Likeness Score: -1.21

References

1. Meyer EA, Äänismaa P, Ertel EA, Hühn E, Strasser DS, Rey M, Murphy MJ, Martinic MM, Pouzol L, Froidevaux S, Keller MP, Caroff E..  (2023)  Discovery of Clinical Candidate ACT-777991, a Potent CXCR3 Antagonist for Antigen-Driven and Inflammatory Pathologies.,  66  (6): [PMID:36883854] [10.1021/acs.jmedchem.3c00074]

Source